在hiPSC衍生的皮层神经元中,阿克罗莱因诱导了形态和应激弹性的改变
Junkai Xie1, Shichen Wu1, Xihui Zhao2
1Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana 47907, United States.
Environmental science & technology
|October 17, 2025
概括
暴露于阿克罗莱因会导致持久的神经毒性影响,包括神经元活动的改变和与阿尔茨海默氏症相关的病理. 这突显了阿克罗莱因在慢性神经退行症中的潜在作用.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 细胞生物学 细胞生物学
背景情况:
- 作为一种反应性氧物种 (ROS),阿克罗莱因与阿尔茨海默氏症和帕金森症等神经退行性疾病有关.
- 尽管已知的直接影响,但对阿克罗莱因暴露的慢性神经毒性影响仍然不清楚.
- 源包括内源性过程 (脂质过氧化) 和环境因素 (吸烟,排放).
研究的目的:
- 为了调查暴露于阿克罗莱因的持续性神经退行性影响.
- 用人类皮层神经元评估神经元功能和病理学的慢性影响.
主要方法:
- 利用人类诱导的多能干细胞 (hiPSC) 衍生的皮质神经元.
- 将神经元暴露在不同度的阿克罗莱因 (0,1,10μM) 中,然后进行放松期.
- 评估了突触密度,神经元活动 (成像,微电极阵列),p-tau病理和线粒体应激.
主要成果:
- 在阿克罗莱因暴露后观察到突触密度和神经元活动的持续变化.
- 剂量依赖的神经元过活性在阿克罗莱因治疗后持续存在.
- 与阿尔茨海默氏症相关的化陶 (p-tau) 病理和线粒体压力的升高.
结论:
- 阿克罗莱因表现出持续的神经毒性作用,长期影响神经元功能和病理.
- 研究结果表明,阿克罗莱因在神经退行性疾病的进展中起着重要作用.
- 这项研究强调了对阿克罗莱因慢性影响的进一步研究的必要性.
相关概念视频
Chromatin Modification in iPS Cells
1.5K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.5K
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K


